Aggregation‐Induced Emission‐Based Macrophage‐Like Nanoparticles for Targeted Photothermal Therapy and Virus Transmission Blockage in Monkeypox

• Published in: Advanced materials (Weinheim) 2024-03, Vol.36 (9), p.e2305378-n/a
• Main Authors: Li, Bin, Wang, Wei, Zhao, Lu, Li, Mengjun, Yan, Dingyuan, Li, Xiaoxue, Zhang, Jie, Gao, Qiuxia, Feng, Yi, Zheng, Judun, Shu, Bowen, Yan, Yan, Wang, Jiamei, Wang, Huanhuan, He, Lingjie, Wu, Yunxia, Zhou, Sitong, Qin, Xinchi, Chen, Wentao, Qiu, Kaizhen, Shen, Chenguang, Wang, Dong, Tang, Ben Zhong, Liao, Yuhui
• Format: Article
• Language: English
• Subjects: aggregation‐induced emission; biomimetic nanoparticles; Biomimetics; Emission; Infrared tracking; Lesions; Membranes; monkeypox; Mpox; Nanoparticles; Public health; targeted photothermal therapy; Ulcers; virus transmission blockage; Viruses
• ISSN: 0935-9648; 1521-4095
• DOI: 10.1002/adma.202305378

The recent prevalence of monkeypox has led to the declaration of a Public Health Emergency of International Concern. Monkeypox lesions are typically ulcers or pustules (containing high titers of replication‐competent virus) in the skin and mucous membranes, which allow monkeypox virus to transmit predominantly through intimate contact. Currently, effective clinical treatments for monkeypox are lacking, and strategies for blocking virus transmission are fraught with drawbacks. Herein, this work constructs a biomimetic nanotemplate (termed TBD@M NPs) with macrophage membranes as the coat and polymeric nanoparticles loading a versatile aggregation‐induced emission featured photothermal molecule TPE‐BT‐DPTQ as the core. In a surrogate mouse model of monkeypox (vaccinia‐virus‐infected tail scarification model), intravenously injected TBD@M NPs show precise tracking and near‐infrared region II fluorescence imaging of the lesions. Upon 808 nm laser irradiation, the virus is eliminated by the photothermal effect and the infected wound heals rapidly. More importantly, the inoculation of treated lesion tissue suspensions does not trigger tail infection or inflammatory activation in healthy mice, indicating successful blockage of virus transmission. This study demonstrates for the first time monkeypox theranostics using nanomedicine, and may bring a new insight into the development of a viable strategy for monkeypox management in clinical trials. A precise therapeutic, prevention, and control strategy for monkeypox, based on an aggregation‐induced emission (AIE) loaded macrophage‐like biomimetic nanoparticle (TBD@M NPs), is developed. TBD@M NPs achieve NIR‐II fluorescent tracking of the monkeypox lesions and photothermal eradication of monkeypox virus after intravenous injection followed by 808 nm laser stimulation, thus accomplishing monkeypox treatment, wound healing promoting, and virus transmission blockage.